Development of a web application and a mobile app to improve breast cancer patient follow-up.
Together with AIM-Apps in Medicine GmbH, AOK Bayern, DAK Gesundheit and Siemens Betriebskrankenkasse (SBK), under the direction of the Klinikum rechts der Isar of the Technical University of Munich (MRI), BITS GmbH participated in the PRISMA study as a consortium partner for the technical infrastructure and developed the PRISMA portal and the “Meine Busenfreundin” app for this purpose. Thirty breast centers throughout Bavaria are participating in the associated study. PRISMA is funded with 3.46 million from the Innovation Fund of the Federal Joint Committee (GBA).
The tasks of BITS here include all digital aspects, including technical IT project management, IT conception, IT architecture and development of the web portal to manage the study and the implementation of the digital questionnaires within the app “Meine Busenfreundin”.
BITS as consortium partner
“Together with BITS GmbH as technical partner for the development of the PRISMA portal and mobile app, we have successfully started the PRISMA study. We want to use this new form of care to improve the quality of life and treatment adherence of breast cancer patients.”

BITS as consortium partner
“Together with BITS GmbH as technical partner for the development of the PRISMA portal and mobile app, we have successfully started the PRISMA study. We want to use this new form of care to improve the quality of life and treatment adherence of breast cancer patients.”

Challenge
Breast cancer is one of the most common cancers in women, with around 70,000 new cases each year. In most cases, for women with hormone-sensitive breast cancer, treatment is not over even after surgery, chemotherapy and radiation therapy. This is followed by years of taking medication, because with the appropriate anti-hormone therapy, the risk of relapse can be halved. Nevertheless, many women discontinue the medication within the first two years.
The reasons for this are the great psychological stress caused by the disease and the side effects caused by taking the medication.
This is where PRISMA (primary hormone-sensitive breast carcinoma) comes in. The goal is to provide patients with new digital, on-demand care to prevent the risk of relapse.
Realization
As one of the consortium partners, BITS is taking care of the technical realization of the digital infrastructure in the project funded by the Innovation Fund of the Federal Joint Committee (GBA). In addition to IT project management, our tasks include IT conception, IT architecture and development of the web portal to manage the study and the implementation of the digital questionnaires within the app “Meine Busenfreundin”.
The app is connected via an interface to the newly developed, web-based platform PRISMA, to which only the treating breast center has access. If the patient repeatedly makes conspicuous statements, PRISMA informs the breast center. There, a specialist can then contact the patient directly and provide advice.
Initially, this will be investigated in 400 female subjects as part of a study. Half will use the app and the other half will receive conventional follow-up. By comparing these two groups in terms of treatment adherence and quality of life, the benefits of digital care will be examined.
Project roles at a glance
BITS experts took on the following roles in this project.
Tools & Technologies
The following tools and technologies were used in this project.
CONTACT
Would you like to find out more?
Are you interested in learning more about the possibilities of digitization in your company? Are you facing similar challenges or have you planned specific projects in your company? Please contact us for a detailed consultation.
Send us an e-mail directly to [email protected] – we look forward to working with you to shape the future of your IT landscape!
You can also make an appointment directly in our calendar.